CVNA
Carvana Co.
CVNA has the edge over NKE overall, supported by stronger fundamentals and stronger modeled upside.
NKE
NIKE, Inc.
NKE has lower modeled downside risk, despite its lower overall score.
CVNA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Healthy | |
| Healthy | |
| Weak |
CVNA's revenue, profitability and cash flow are currently healthy, but its balance sheet is weak.
NKE Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Healthy | |
| Stable | |
| Strong |
NKE's profitability and balance sheet are currently healthy, and its revenue and cash flow are stable.
CVNA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 34x | $70.84 | — |
| Forward | 35x | $70.84 | — |
| Cheap | 36x | $75.86 | +7.1% |
| Fair | 83x | $173 | +144% |
| Expensive | 113x | $235 | +231% |
Historical ranges are pointers, not guarantees.
CVNA's PE is in its cheap range at 34x. On analysts' estimates for next year's earnings, today's price would be 35x.
NKE PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Current | 18x | $37.76 | — |
| Cheap | 23x | $47.70 | +26% |
| Forward | 30x | $37.76 | — |
| Fair | 33x | $68.16 | +80% |
| Expensive | 47x | $97.86 | +159% |
Historical ranges are pointers, not guarantees.
NKE's PE is in its cheap range at 18x. On analysts' estimates for next year's earnings, today's price would be 30x, in its fair range.
CVNA Forward outlook
| Metric | Outlook |
|---|---|
| Stable | |
| Strong growth | |
| Strong growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect strong earnings and revenue growth for CVNA, with profitability holding steady. However, they disagree widely on these estimates.
NKE Forward outlook
| Metric | Outlook |
|---|---|
| Strongly deteriorating | |
| Stable | |
| Decline | |
| Improving | |
| Moderate | |
| Low |
Analysts expect NKE's profitability to improve, but its revenue to decline. However, they disagree widely on these estimates.
CVNA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.05 | -1.4% |
| Q3 2026 | $2.08 | +136% |
| Q2 2026 | $1.89 | +136% |
| Q1 2026 | $1.73 | +204% |
| Q4 2025 | $1.69 | +428% |
| Q3 2023 | -$1.22 | +$0.57 |
| Q2 2023 | -$2.51 | -$1.18 |
| Q1 2023 | -$2.87 | -$2.06 |
| Q4 2022 | -$3.15 | -$2.82 |
CVNA has the edge over NKE on earnings, with more consistent year-over-year improvement.
NKE Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $1.27 | -39% |
| Q3 2026 | $2.09 | +7.2% |
| Q2 2026 | $2.10 | -2.8% |
| Q1 2026 | $1.51 | -50% |
| Q4 2025 | $1.70 | -48% |
| Q3 2025 | $1.95 | -44% |
| Q2 2025 | $2.16 | -42% |
| Q1 2025 | $3.01 | -11% |
| Q4 2024 | $3.24 | -5.3% |
NKE's earnings per share have fallen from their peak: $2.09 over the past year, against $3.82 in late 2021.
CVNA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $8B | +42% |
| Q2 2026 | $7.4B | +52% |
| Q1 2026 | $6.4B | +52% |
| Q4 2025 | $5.6B | +58% |
| Q3 2025 | $5.6B | +55% |
| Q2 2025 | $4.8B | +42% |
| Q1 2025 | $4.2B | +38% |
| Q4 2024 | $3.5B | +46% |
CVNA has the edge over NKE on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.9% | -0.9 points |
| Q2 2026 | 9.2% | -1.4 points |
| Q1 2026 | 9% | -0.3 points |
| Q4 2025 | 7.6% | +0.2 points |
| Q3 2025 | 9.8% | +0.5 points |
| Q2 2025 | 11% | +3 points |
| Q1 2025 | 9.3% | +4.9 points |
| Q4 2024 | 7.3% | N/A |
CVNA has the edge over NKE on profitability, with a higher operating margin.
NKE Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11.2B | -4.3% |
| Q2 2026 | $11B | -1.1% |
| Q1 2026 | $11.3B | +0.1% |
| Q4 2025 | $12.4B | +0.6% |
| Q3 2025 | $11.7B | +1.1% |
| Q2 2025 | $11.1B | -12% |
| Q1 2025 | $11.3B | -9.3% |
| Q4 2024 | $12.4B | -7.7% |
NKE's revenue fell from its 2023 peak and has held roughly level since: $11.2B last quarter, down 4.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 8.2% | +0.3 points |
| Q2 2026 | 12% | +9.2 points |
| Q1 2026 | 5.8% | -1.7 points |
| Q4 2025 | 8% | -3.4 points |
| Q3 2025 | 7.9% | -3.4 points |
| Q2 2025 | 2.9% | -11 points |
| Q1 2025 | 7.5% | -3.8 points |
| Q4 2024 | 11% | -2.9 points |
NKE's operating margin was 8.2% last quarter, about level with the same quarter a year ago.
CVNA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $491M | +60% |
| Q2 2026 | $187M | +$189M |
| Q1 2026 | $56M | -73% |
| Q4 2025 | $379M | +953% |
| Q3 2025 | $307M | -18% |
| Q2 2025 | -$2M | -101% |
| Q1 2025 | $205M | +147% |
| Q4 2024 | $36M | +$293M |
CVNA has the edge over NKE on cash flow, with more consistent year-over-year improvement.
NKE Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$64M | -527% |
| Q2 2026 | $1.5B | +313% |
| Q1 2026 | $284M | -83% |
| Q4 2025 | $386M | -58% |
| Q3 2025 | $15M | -95% |
| Q2 2025 | $363M | -85% |
| Q1 2025 | $1.7B | -11% |
| Q4 2024 | $920M | -65% |
NKE usually generates cash, though not every quarter: the latest was −$64M, but it generated $2.1B over the past year.
CVNA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | -50K shares |
| 1 year | +3.3% | +23.8M shares |
| 3 years | +40% | +211M shares |
| 5 years | +123% | +408M shares |
CVNA has 740M diluted shares, up 3.3% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2026 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q3 2024 | $2M |
| Q2 2024 | — |
| Q1 2024 | — |
| Q3 2023 | — |
NKE Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.2% | +3.2M shares |
| 1 year | +0.4% | +5.2M shares |
| 3 years | -3.8% | -59.1M shares |
| 5 years | -8.4% | -135M shares |
| Available history | -6.9% | -110M shares |
NKE has the edge over CVNA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | $20M |
| Q3 2025 | $126M |
| Q2 2025 | $199M |
| Q1 2025 | $506M |
| Q4 2024 | $1.1B |
NKE has spent almost nothing on buybacks in the past year.
CVNA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2021 | 186.0x | High |
| Q2 2021 | 128.9x | High |
CVNA's net debt is more than 20 years of its operating earnings (EBITDA).
NKE Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 0.2x | Very low |
| Q2 2026 | 0.1x | Very low |
| Q1 2025 | 0.1x | Very low |
| Q4 2024 | 0.2x | Very low |
| Q3 2024 | 0.1x | Very low |
| Q2 2024 | -0.1x | Net Cash |
| Q1 2024 | -0.0x | Very low |
| Q4 2023 | 0.1x | Very low |
NKE's net debt is less than a year of its operating earnings (EBITDA).
CVNA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 52.9 | Neutral |
| Stochastic | 67.9 | Neutral |
CVNA's weekly RSI is 53 (neutral) and its Stochastic is 68 (neutral).
NKE Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.0 | Neutral |
| Stochastic | 57.5 | Neutral |
NKE's weekly RSI is 40 (neutral) and its Stochastic is 58 (neutral).
CVNA PE vs Consumer Cyclical Sector
| Metric | CVNA | Sector median | Relative |
|---|---|---|---|
| PE | 34x | 18x | 89% above |
| PE % | 8 | 47 | 39 pts below |
CVNA is trading at 34x earnings, a 89% premium to the Consumer Cyclical sector's median of 18x.
NKE PE vs Consumer Cyclical Sector
| Metric | NKE | Sector median | Relative |
|---|---|---|---|
| PE | 18x | 18x | 0.3% above |
| PE % | 2 | 47 | 45 pts below |
NKE has the edge over CVNA on valuation relative to its sector.
CVNA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $65.2 | 8.6% above |
| 20 week MA | $67.3 | 5.3% above |
| 50 week MA | $71.3 | 0.7% below |
| 100 week MA | $64.7 | 9.5% above |
| 200 week MA | $40.2 | 76% above |
CVNA has the edge over NKE on trend strength, trading above more of its moving averages.
NKE Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $36.7 | 2.8% above |
| 20 week MA | $39.2 | 3.6% below |
| 50 week MA | $48.0 | 21% below |
| 100 week MA | $58.4 | 35% below |
| 200 week MA | $79.2 | 52% below |
NKE has bounced recently, but its long-term trend is still down: it's above its 8-week average, but 52% below its 200-week average.
CVNA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.6 | $54.9 | +181% |
| 2021 | $54.9 | $48.2 | -12% |
| 2022 | $48.2 | $0.81 | -98% |
| 2023 | $0.81 | $10.6 | +1207% |
| 2024 | $10.6 | $43.0 | +306% |
| 2025 | $43.0 | $87.7 | +104% |
| 2026 YTD | $87.7 | $70.8 | -19% |
CVNA has the edge over NKE on returns for 2026, with the stronger performance.
NKE Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $101.6 | $141.6 | +39% |
| 2021 | $141.6 | $165.7 | +17% |
| 2022 | $165.7 | $116.3 | -30% |
| 2023 | $116.3 | $108.6 | -6.6% |
| 2024 | $108.6 | $76.4 | -30% |
| 2025 | $76.4 | $60.9 | -20% |
| 2026 YTD | $60.9 | $37.8 | -38% |
NKE has finished four years in a row lower, and it's down 38% so far in 2026.